Evidence map›Paper›PMID 24828506›Full record

ArticleThe Journal of biological chemistry2014

Expression of the bacterial type III effector DspA/E in Saccharomyces cerevisiae down-regulates the sphingolipid biosynthetic pathway leading to growth arrest.

Sabrina Siamer, Isabelle Guillas, Mitsugu Shimobayashi, Caroline Kunz, Michael N Hall, Marie-Anne Barny

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Extracellular niche establishment by plant pathogens.Nature reviews. Microbiology · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. DspA/E-Triggered Non-Host Resistance againstInternational journal of molecular sciences · 2022
    Article
  9. Plant susceptible responses: the underestimated side of plant-pathogen interactions.Biological reviews of the Cambridge Philosophical Society · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Virulence Factors of Erwinia amylovora: A Review.International journal of molecular sciences · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sabrina SiamerFrom the Institut National de la Recherche Agronomique UMR1392, Institut d'Ecologie et des Sciences de l'Environnement, Université Pierre et Marie Curie (UPMC), Bât A 7ème Etage Case 237, 7 Quai St.-Bernard, 75252 Paris, France, Biozentrum, University of Basel, CH-4056 Basel, Switzerland.
Isabelle GuillasSorbonne Universités, UMR1166, Institut National de la Santé et de la recherche médicale-UPMC, Pitié-Salpétrière University Hospital, F75013, Paris, France.
Mitsugu ShimobayashiBiozentrum, University of Basel, CH-4056 Basel, Switzerland.
Caroline KunzSorbonne Universités, UPMC University Paris 06, UFR 927, F-75005 Paris, France, and Muséum National d'Histoire Naturelle, UMR7245, Molécules de Communication et Adaptation des Micro-organismes, F-75005 Paris, France.
Michael N HallBiozentrum, University of Basel, CH-4056 Basel, Switzerland.
Marie-Anne BarnyFrom the Institut National de la Recherche Agronomique UMR1392, Institut d'Ecologie et des Sciences de l'Environnement, Université Pierre et Marie Curie (UPMC), Bât A 7ème Etage Case 237, 7 Quai St.-Bernard, 75252 Paris, France, barny@agroparistech.fr marie-anne.barny@upmc.fr.
University of Basel · CHSorbonne Université · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Erwinia amylovora, the bacterium responsible for fire blight, relies on a type III secretion system and a single injected effector, DspA/E, to induce disease in host plants. DspA/E belongs to the widespread AvrE family of type III effectors that suppress plant defense responses and promote bacterial growth following infection. Ectopic expression of DspA/E in plant or in Saccharomyces cerevisiae is toxic, indicating that DspA/E likely targets a cellular process conserved between yeast and plant. To unravel the mode of action of DspA/E, we screened the Euroscarf S. cerevisiae library for mutants resistant to DspA/E-induced growth arrest. The most resistant mutants (Δsur4, Δfen1, Δipt1, Δskn1, Δcsg1, Δcsg2, Δorm1, and Δorm2) were impaired in the sphingolipid biosynthetic pathway. Exogenously supplied sphingolipid precursors such as the long chain bases (LCBs) phytosphingosine and dihydrosphingosine also suppressed the DspA/E-induced yeast growth defect. Expression of DspA/E in yeast down-regulated LCB biosynthesis and induced a rapid decrease in LCB levels, indicating that serine palmitoyltransferase (SPT), the first and rate-limiting enzyme of the sphingolipid biosynthetic pathway, was repressed. SPT down-regulation was mediated by dephosphorylation and activation of Orm proteins that negatively regulate SPT. A Δcdc55 mutation affecting Cdc55-PP2A protein phosphatase activity prevented Orm dephosphorylation and suppressed DspA/E-induced growth arrest.

Indexed as

Down-RegulationBacterial ProteinsBiosynthetic PathwaysGene ExpressionSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSerine C-PalmitoyltransferaseSphingolipidsBacterial ProteinsDspA protein, Erwinia amylovoraSaccharomyces cerevisiae ProteinsSerine C-PalmitoyltransferaseSphingolipidsCell GrowthDspA/EHost-Pathogen InteractionLong Chain BasesOrm RegulationPhosphataseSerine PalmitoyltransferaseSphingolipidType III EffectorYeast Genetics

Identifiers

PMID24828506
PMCPMC4140250
OpenAlexW2077610943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.